HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-JUN-13 4L7P TITLE HUMAN ARTD3 (PARP3) - CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR TITLE 2 ME0395 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC PARP DOMAIN; COMPND 5 SYNONYM: PARP-3, HPARP-3, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN- COMPND 6 LIKE 3, ARTD3, IRT1, NAD(+) ADP-RIBOSYLTRANSFERASE 3, ADPRT-3, COMPND 7 POLY[ADP-RIBOSE] SYNTHASE 3, PADPRT-3; COMPND 8 EC: 2.4.2.30; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADPRT3, ADPRTL3, PARP3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) R3 PRARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-BSA4 KEYWDS DIPHTHERIA TOXIN LIKE ADP-RIBOSE TRASNFERASE, TRANSFERASE, ADP- KEYWDS 2 RIBOSYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.G.THORSELL,A.E.G.LINDGREN,T.EKBLAD,S.SPJUT, AUTHOR 2 C.D.ANDERSSON,J.WEIGELT,A.LINUSSON,M.ELOFSSON,H.SCHULER REVDAT 1 19-FEB-14 4L7P 0 JRNL AUTH A.E.LINDGREN,T.KARLBERG,T.EKBLAD,S.SPJUT,A.G.THORSELL, JRNL AUTH 2 C.D.ANDERSSON,T.T.NHAN,V.HELLSTEN,J.WEIGELT,A.LINUSSON, JRNL AUTH 3 H.SCHULER,M.ELOFSSON JRNL TITL CHEMICAL PROBES TO STUDY ADP-RIBOSYLATION: SYNTHESIS AND JRNL TITL 2 BIOCHEMICAL EVALUATION OF INHIBITORS OF THE HUMAN JRNL TITL 3 ADP-RIBOSYLTRANSFERASE ARTD3/PARP3. JRNL REF J.MED.CHEM. V. 56 9556 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24188023 JRNL DOI 10.1021/JM401394U REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 15206 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1216 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.46 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.88 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2745 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1867 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2525 REMARK 3 BIN R VALUE (WORKING SET) : 0.1829 REMARK 3 BIN FREE R VALUE : 0.2291 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 220 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2723 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 46 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.32700 REMARK 3 B22 (A**2) : 9.07310 REMARK 3 B33 (A**2) : -4.74620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.33310 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.251 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.350 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2810 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3807 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1297 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 85 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 403 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2810 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 358 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3065 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.30 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.84 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|177 - A|532 } REMARK 3 ORIGIN FOR THE GROUP (A): 2.2220 -0.5828 22.8490 REMARK 3 T TENSOR REMARK 3 T11: -0.0873 T22: -0.0978 REMARK 3 T33: -0.0374 T12: -0.0187 REMARK 3 T13: 0.0149 T23: -0.0035 REMARK 3 L TENSOR REMARK 3 L11: 0.6632 L22: 1.1064 REMARK 3 L33: 1.0443 L12: -0.1790 REMARK 3 L13: 0.0976 L23: -0.3052 REMARK 3 S TENSOR REMARK 3 S11: 0.0452 S12: -0.0825 S13: -0.0143 REMARK 3 S21: 0.1086 S22: 0.0188 S23: 0.1345 REMARK 3 S31: -0.0072 S32: -0.0330 S33: -0.0640 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4L7P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUN-13. REMARK 100 THE RCSB ID CODE IS RCSB080285. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15221 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : 0.10600 REMARK 200 FOR THE DATA SET : 19.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.60300 REMARK 200 R SYM FOR SHELL (I) : 0.52300 REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 4GV4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.9M DL-MALIC ACID, 0.1M BIS-TRIS- REMARK 280 PROPANE , PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.26750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMERIC REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 176 REMARK 465 GLY A 242 REMARK 465 PRO A 243 REMARK 465 THR A 244 REMARK 465 ASP A 245 REMARK 465 GLY A 246 REMARK 465 GLY A 247 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 191 CD CE NZ REMARK 470 GLU A 251 CD OE1 OE2 REMARK 470 HIS A 267 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 350 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 351 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 375 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 350 -60.17 -93.41 REMARK 500 HIS A 373 13.92 -143.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE M95 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4L6Z RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH STO1168. REMARK 900 RELATED ID: 4L70 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ME0352. REMARK 900 RELATED ID: 4L7L RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ME0368. REMARK 900 RELATED ID: 4L7N RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH STO1541. REMARK 900 RELATED ID: 4L7O RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH STO1542. REMARK 900 RELATED ID: 4L7R RELATED DB: PDB REMARK 900 RELATED ID: 4L7U RELATED DB: PDB DBREF 4L7P A 178 532 UNP Q9Y6F1 PARP3_HUMAN 178 532 SEQADV 4L7P SER A 176 UNP Q9Y6F1 EXPRESSION TAG SEQADV 4L7P MET A 177 UNP Q9Y6F1 EXPRESSION TAG SEQRES 1 A 357 SER MET LYS ARG VAL GLN PRO CYS SER LEU ASP PRO ALA SEQRES 2 A 357 THR GLN LYS LEU ILE THR ASN ILE PHE SER LYS GLU MET SEQRES 3 A 357 PHE LYS ASN THR MET ALA LEU MET ASP LEU ASP VAL LYS SEQRES 4 A 357 LYS MET PRO LEU GLY LYS LEU SER LYS GLN GLN ILE ALA SEQRES 5 A 357 ARG GLY PHE GLU ALA LEU GLU ALA LEU GLU GLU ALA LEU SEQRES 6 A 357 LYS GLY PRO THR ASP GLY GLY GLN SER LEU GLU GLU LEU SEQRES 7 A 357 SER SER HIS PHE TYR THR VAL ILE PRO HIS ASN PHE GLY SEQRES 8 A 357 HIS SER GLN PRO PRO PRO ILE ASN SER PRO GLU LEU LEU SEQRES 9 A 357 GLN ALA LYS LYS ASP MET LEU LEU VAL LEU ALA ASP ILE SEQRES 10 A 357 GLU LEU ALA GLN ALA LEU GLN ALA VAL SER GLU GLN GLU SEQRES 11 A 357 LYS THR VAL GLU GLU VAL PRO HIS PRO LEU ASP ARG ASP SEQRES 12 A 357 TYR GLN LEU LEU LYS CYS GLN LEU GLN LEU LEU ASP SER SEQRES 13 A 357 GLY ALA PRO GLU TYR LYS VAL ILE GLN THR TYR LEU GLU SEQRES 14 A 357 GLN THR GLY SER ASN HIS ARG CYS PRO THR LEU GLN HIS SEQRES 15 A 357 ILE TRP LYS VAL ASN GLN GLU GLY GLU GLU ASP ARG PHE SEQRES 16 A 357 GLN ALA HIS SER LYS LEU GLY ASN ARG LYS LEU LEU TRP SEQRES 17 A 357 HIS GLY THR ASN MET ALA VAL VAL ALA ALA ILE LEU THR SEQRES 18 A 357 SER GLY LEU ARG ILE MET PRO HIS SER GLY GLY ARG VAL SEQRES 19 A 357 GLY LYS GLY ILE TYR PHE ALA SER GLU ASN SER LYS SER SEQRES 20 A 357 ALA GLY TYR VAL ILE GLY MET LYS CYS GLY ALA HIS HIS SEQRES 21 A 357 VAL GLY TYR MET PHE LEU GLY GLU VAL ALA LEU GLY ARG SEQRES 22 A 357 GLU HIS HIS ILE ASN THR ASP ASN PRO SER LEU LYS SER SEQRES 23 A 357 PRO PRO PRO GLY PHE ASP SER VAL ILE ALA ARG GLY HIS SEQRES 24 A 357 THR GLU PRO ASP PRO THR GLN ASP THR GLU LEU GLU LEU SEQRES 25 A 357 ASP GLY GLN GLN VAL VAL VAL PRO GLN GLY GLN PRO VAL SEQRES 26 A 357 PRO CYS PRO GLU PHE SER SER SER THR PHE SER GLN SER SEQRES 27 A 357 GLU TYR LEU ILE TYR GLN GLU SER GLN CYS ARG LEU ARG SEQRES 28 A 357 TYR LEU LEU GLU VAL HIS HET M95 A 601 26 HETNAM M95 (2E)-N-[(2S)-1-HYDROXY-3-PHENYLPROPAN-2-YL]-3-(4-OXO-1, HETNAM 2 M95 4-DIHYDROQUINAZOLIN-2-YL)PROP-2-ENAMIDE FORMUL 2 M95 C20 H19 N3 O3 FORMUL 3 HOH *46(H2 O) HELIX 1 1 ASP A 186 PHE A 197 1 12 HELIX 2 2 SER A 198 MET A 209 1 12 HELIX 3 3 SER A 222 LYS A 241 1 20 HELIX 4 4 SER A 249 ILE A 261 1 13 HELIX 5 5 SER A 275 GLN A 299 1 25 HELIX 6 6 SER A 302 THR A 307 1 6 HELIX 7 7 HIS A 313 LEU A 322 1 10 HELIX 8 8 ALA A 333 GLY A 347 1 15 HELIX 9 9 GLY A 365 GLN A 371 1 7 HELIX 10 10 ALA A 372 SER A 374 5 3 HELIX 11 11 ASN A 387 ALA A 389 5 3 HELIX 12 12 VAL A 390 GLY A 398 1 9 HELIX 13 13 GLU A 418 GLY A 424 1 7 HELIX 14 14 PRO A 479 ASP A 482 5 4 HELIX 15 15 PRO A 503 SER A 506 5 4 HELIX 16 16 GLN A 519 SER A 521 5 3 SHEET 1 A 2 ARG A 179 VAL A 180 0 SHEET 2 A 2 GLU A 310 VAL A 311 1 O VAL A 311 N ARG A 179 SHEET 1 B 5 CYS A 324 LEU A 328 0 SHEET 2 B 5 THR A 354 GLN A 363 -1 O LYS A 360 N GLN A 327 SHEET 3 B 5 CYS A 523 HIS A 532 -1 O LEU A 528 N TRP A 359 SHEET 4 B 5 HIS A 434 ALA A 445 -1 N GLU A 443 O ARG A 524 SHEET 5 B 5 ARG A 379 GLY A 385 -1 N LEU A 382 O GLY A 442 SHEET 1 C 5 CYS A 324 LEU A 328 0 SHEET 2 C 5 THR A 354 GLN A 363 -1 O LYS A 360 N GLN A 327 SHEET 3 C 5 CYS A 523 HIS A 532 -1 O LEU A 528 N TRP A 359 SHEET 4 C 5 HIS A 434 ALA A 445 -1 N GLU A 443 O ARG A 524 SHEET 5 C 5 MET A 429 CYS A 431 -1 N CYS A 431 O HIS A 434 SHEET 1 D 4 ILE A 413 PHE A 415 0 SHEET 2 D 4 GLU A 514 ILE A 517 -1 O TYR A 515 N PHE A 415 SHEET 3 D 4 SER A 468 ALA A 471 -1 N VAL A 469 O LEU A 516 SHEET 4 D 4 GLU A 449 ILE A 452 1 N HIS A 450 O ILE A 470 SHEET 1 E 2 THR A 475 PRO A 477 0 SHEET 2 E 2 PRO A 499 PRO A 501 -1 O VAL A 500 N GLU A 476 SHEET 1 F 2 THR A 483 LEU A 487 0 SHEET 2 F 2 GLN A 490 VAL A 494 -1 O GLN A 490 N LEU A 487 SITE 1 AC1 9 HIS A 384 GLY A 385 THR A 386 TYR A 414 SITE 2 AC1 9 PHE A 415 SER A 422 TYR A 425 ILE A 427 SITE 3 AC1 9 GLU A 514 CRYST1 56.876 56.535 58.622 90.00 114.26 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017582 0.000000 0.007924 0.00000 SCALE2 0.000000 0.017688 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018711 0.00000 MASTER 286 0 1 16 20 0 3 6 0 0 0 28 END